the disease is self-limiting and usually remits within 5 years
the mortality rate prior to the use of oral corticosteroids was reported in 1953 to be 24%; the mortality rates today vary between 6% and 41%
patients with bullous pemphigoid (BP) are generally elderly, often on multiple therapies and at high risk of adverse drug reactions and side-effects. High doses of immunosuppressants may put these patients at risk of life-threatening adverse effects more dangerous than the BP (1)
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.